Lipids control mucus production in cystic fibrosis.
Gulbins
Erich
E
Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany. erich.gulbins@uni-due.de
D000818:Animals; D024402:Carbonic Anhydrase II / Q000096:biosynthesis; D030741:Carbonic Anhydrase IV / Q000096:biosynthesis; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000172:deficiency / Q000502:physiology; D015232:Dinoprostone / Q000031:analogs & derivatives / Q000378:metabolism; D004195:Disease Models, Animal; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D018181:Mice, Inbred CFTR / Q000502:physiology; D009093:Mucus / Q000378:metabolism*; D047495:PPAR gamma / Q000502:physiology*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000494:pharmacology / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C026346:15-ketoprostaglandin E2; D024402:Carbonic Anhydrase II; D030741:Carbonic Anhydrase IV; D015232:Dinoprostone